The Asian Pacific Association for the Study of the Liver [APASL]

Subscription of Journal

Dear members,
Hepatology International extends its Warmest Greetings !
As we step into yet another year of new targets, renewed expectations and hope, with reflections of the successes and limitations of the passing year, we would like to express our sincere thanks and gratitude to all our members who have remained an integral part of the Hepatology International through its journey all these years.
The journal, under the able guidance and leadership of Prof Masao Omata and Prof Shiv Sarin, has come a long way since its inception in 2007, establishing itself in the field of Hepatology and Biliary Sciences, earning a place in PubMed and ISI, and achieving a distinct impact factor of 9.029 for the year 2021 .
We would like to take this opportunity to encourage each one of you to continue to align with us and extend your gracious support and cooperation to the journal in the coming years.
We look forward to a deeply cherished association with you.

With warmest regards,

Prof. Masao Omata Prof. Shiv K. Sarin
EIC Hepatology International EIC Hepatology International

New articles on COVID-19

4 new articles on COVID-19 and the liverhave been
recently published onlinein Hepatology International.

1. Editorial: Fast, faster, and fastest: science on the run during COVID-19 drama”—”do not forget the liver: https://link.springer.com/article/10.1007/s12072-020-10042-0  

2. Consensus: Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation: https://link.springer.com/article/10.1007/s12072-020-10043-z

3. Guidelines: Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI): https://link.springer.com/article/10.1007/s12072-020-10041-1

4. SARS-Cov-2 (human) and COVID-19: Primer 2020 https://link.springer.com/article/10.1007/s12072-020-10049-7

Guidelines
    Now the nine APASL Guidelines have been published in Hepatol International!!! APASL Guidelines for HBV (Hepatol Int 2016; 10: 1–98), APASL Guidelines for HCV (Hepatol Int 2016; 10: 681–726), APASL Guidelines for HCC (Hepatol Int 2017; 11: 317-370), APASL Guidelines for Acute-on-chronic Liver Failure (Hepatol Int 2014; 8: 453-471), APASL Guidelines for Fibrosis (Hepatol Int 2009; 3: 323-333), APASL consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis a 2016 update (Hepatol Int 2017; 11:1–30), APASL Guidelines for IPH (Hepatol Int 2007; 1: 398-413), APASL Guidelines for Variceal Bleeding (Hepatol Int 2008; 2: 429-439)
HEPATOLOGY INTERNATIONAL
  • This official journal was launched in 2007 and publishes the abstracts of the Annual Meeting, original and review articles, and APASL guidelines.
  • The journal is issued bimonthly and growing rapidly. We received over 400 manuscript submissions in a year and the acceptance rate of original article is now 10 to 20%.
  • The Impact Factor of 2018 was 5.49.
ONLINE SUBSCRIPTION
  • APASL members are able to access on-line subscription page.
SUBSCRIPTION BY PRINT COPY
  • To have print copy of Hepatology International, please follow the steps below to renew your　APASL MEMBERSHIP and pay for the subscription to the journal　HEPATOLOGY INTERNATIONAL.
    • Click this“Online Application and Subscription Form”
    • Input your information directly to “APASL Membership Application and Subscription Form” on the web.
    • Submit the “APASL Membership Application and Hepatology International Subscription” to us by clicking the submission button.